Shares of pharmaceutical companies were trading under pressure with the frontline stocks like Sun Pharmaceutical Industries, Lupin and Dr Reddy’s Laboratories hitting their respective 52-week lows in early morning deals.
At 10:23 am; Nifty Pharma index, the largest loser among sectoral indices, was down 1.5% as compared to a marginal 0.02% decline in the Nifty 50 index. In past three trading sessions, the pharma index slipped 3.3% as against 1% fall in the benchmark index.
Among the individual stocks, Biocon has slipped 8% to Rs 347 after the US Food and Drug Administration (FDA) issued Form 483 with
At 10:23 am; Nifty Pharma index, the largest loser among sectoral indices, was down 1.5% as compared to a marginal 0.02% decline in the Nifty 50 index. In past three trading sessions, the pharma index slipped 3.3% as against 1% fall in the benchmark index.
Among the individual stocks, Biocon has slipped 8% to Rs 347 after the US Food and Drug Administration (FDA) issued Form 483 with